American Samoa vs Cameroon: Treatment coverage for lymphatic filariasis
American Samoa
33.9%
in 2022
Cameroon
33.8%
in 2021
American Samoa rank
45th
Cameroon rank
46th
Treatment coverage for lymphatic filariasis over time
- American Samoa
- Cameroon
How they compare
American Samoa currently reports 33.9% against 33.8% in Cameroon, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2008 it was Cameroon ahead.
American Samoa ranks 45th and Cameroon ranks 46th of 66 countries.
Across the 3 decades both report, American Samoa averaged higher in 1 and Cameroon in 2.
Head to head by decade
| Decade | American Samoa | Cameroon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 6.2% | 6.2% | Cameroon |
| 2010s | 49.9% | 45.1% | 4.8% | American Samoa |
| 2020s | 0.0% | 16.9% | 16.9% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, American Samoa or Cameroon?
- American Samoa, at 33.9% against 33.8% in Cameroon as of 2022.
- What is the difference in treatment coverage for lymphatic filariasis between American Samoa and Cameroon?
- 0.1%, with American Samoa ahead.
- How many years of comparable data are there for American Samoa and Cameroon?
- 6 years are reported by both, from 2008 to 2021.
- How do American Samoa and Cameroon rank globally for treatment coverage for lymphatic filariasis?
- American Samoa ranks 45th and Cameroon ranks 46th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.